Starting in July, certain Medicare enrollees can pay $50 a month for specific prescription GLP1 medications, according to the Centers for Medicare and Medicaid Services
Value cost savings over FDA-approval of finished product: If you understand the difference between FDA-approved and compounded medications, recognize that compounded versions haven't undergone the same regulatory review process, and prioritize affordability when insurance doesn't cover GLP-1s for weight loss, Yucca Health's compounded formulations offer significant cost savings
In the medical aesthetics sector, the impact is already being felt
Does PlexusDx require proof of age before prescribing tirzepatide
Things to Know Pregnancy and Nursing: Talk to your doctor if you are pregnant or breastfeeding
Section 503A and 503B of the Federal Food, Drug, and Cosmetic Act prohibit physicians, pharmacies, and outsourcing facilities from compounding essential copies of commercially available approved drugs